Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

ConditionDelirium, Postoperative

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age60+

SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

This study aims to clarify the preventive effect of perioperative liraglutide application on postoperative delirium in elderly patients with Type 2 diabetes undergoing cardiac surgery.

Eligibility criteria

Qualifiers

Age ≥ 60 years

Type 2 diabetes

Patients undergoing elective cardiac surgery

Disqualifiers

History of neurological or psychiatric disorders, such as schizophrenia, epilepsy, Parkinson's disease, severe dementia, etc

Patients with communication difficulties, such as severe visual, auditory, or speech impairments

History of central nervous system damage or surgery

Cardiac function NYHA Class IV

Trial design

Treatments tested in this trial

Liraglutide injection
Placebo injection

Treatment groups

260 Participants

are divided into 2 treatment groups

Sponsors and collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Lead sponsor

Source ClinicalTrials.gov